{"log_id": 5243558518767866233, "direction": 0, "words_result_num": 37, "words_result": [{"probability": {"variance": 2e-06, "average": 0.998883, "min": 0.994713}, "location": {"width": 331, "top": 238, "height": 40, "left": 234}, "words": "本品为处方药品,凭医生处方用药"}, {"probability": {"variance": 3e-06, "average": 0.999005, "min": 0.992606}, "location": {"width": 810, "top": 278, "height": 57, "left": 235}, "words": "在给予有子宫的绝经后妇女进行雌激素治疗时,应该同时加用孕激素,以减少发生子"}, {"probability": {"variance": 0.000362, "average": 0.993844, "min": 0.883964}, "location": {"width": 836, "top": 310, "height": 56, "left": 186}, "words": "宫内膜癌的风险。无子宫的妇女则不必加用孕激素。雌激素单独使用或与孕激素联合使"}, {"probability": {"variance": 8e-06, "average": 0.998511, "min": 0.986744}, "location": {"width": 858, "top": 339, "height": 57, "left": 186}, "words": "用,需在权衡妇女个体治疗目标和风险的情况下,使用最低有效剂量和最短疗程。患者应"}, {"probability": {"variance": 2.5e-05, "average": 0.997782, "min": 0.971618}, "location": {"width": 854, "top": 370, "height": 55, "left": 189}, "words": "该根据临床需要定期(如每3个月或者6个月)进行再评估,来决定是否仍然需要治疗(见"}, {"probability": {"variance": 0.000331, "average": 0.994186, "min": 0.900509}, "location": {"width": 836, "top": 399, "height": 55, "left": 198}, "words": "注意事项]一警告)。对于有子宫的妇女,当出现诊断不明的长期或反复的阴道异常出"}, {"probability": {"variance": 0.000124, "average": 0.995661, "min": 0.943651}, "location": {"width": 722, "top": 432, "height": 52, "left": 189}, "words": "血时,应采取充分的诊断措施,如:子宫内膜活检,以排除恶性疾病的可能"}, {"probability": {"variance": 0.009437, "average": 0.974601, "min": 0.507449}, "location": {"width": 864, "top": 483, "height": 58, "left": 187}, "words": "1.治疗中-重度与绝经相关的血管舒缩症状和/或外阴和阴道萎缩。当仅为了治疗外阴和阴"}, {"probability": {"variance": 2.6e-05, "average": 0.996387, "min": 0.978496}, "location": {"width": 396, "top": 525, "height": 42, "left": 226}, "words": "道萎缩症状,应考虑阴道局部用药的产品"}, {"probability": {"variance": 0.000448, "average": 0.991426, "min": 0.878582}, "location": {"width": 819, "top": 566, "height": 55, "left": 225}, "words": "应该给患者使用最低的有效剂量。通常宜从每日0.3mg倍美力开始,随后剂量的调整"}, {"probability": {"variance": 8e-06, "average": 0.998539, "min": 0.988612}, "location": {"width": 812, "top": 595, "height": 54, "left": 225}, "words": "要根据患者个体反应。医生应该定期对药物剂量进行重新评价,决定治疗是否仍然必"}, {"probability": {"variance": 0, "average": 0.999903, "min": 0.999903}, "location": {"width": 24, "top": 652, "height": 24, "left": 227}, "words": "要"}, {"probability": {"variance": 0.000174, "average": 0.996214, "min": 0.921836}, "location": {"width": 803, "top": 678, "height": 57, "left": 227}, "words": "根据患者个体情况及医疗需要,倍美力治疗可以采用不间断用药或周期性用药方案"}, {"probability": {"variance": 0.000187, "average": 0.99253, "min": 0.950437}, "location": {"width": 326, "top": 723, "height": 40, "left": 251}, "words": "如服药25天,随后停药5天的疗法)"}, {"probability": {"variance": 0.00069, "average": 0.990815, "min": 0.9038}, "location": {"width": 256, "top": 781, "height": 39, "left": 192}, "words": "2.预防和控制骨质疏松症"}, {"probability": {"variance": 0.020408, "average": 0.917663, "min": 0.637658}, "location": {"width": 266, "top": 717, "height": 102, "left": 835}, "words": "感氏制药有限公司"}, {"probability": {"variance": 1e-06, "average": 0.999246, "min": 0.997106}, "location": {"width": 810, "top": 791, "height": 56, "left": 231}, "words": "当仅为了预防和控制骨质疏松症,应仅在有明显骨质疏松危险的妇女和被认为不适合"}, {"probability": {"variance": 0.002923, "average": 0.977691, "min": 0.787659}, "location": {"width": 815, "top": 822, "height": 54, "left": 229}, "words": "非雌激素疗法的妇女才考虑使用。应该给患者进行最低的有效剂量治疗缝常宜每"}, {"probability": {"variance": 0.005934, "average": 0.982662, "min": 0.513708}, "location": {"width": 814, "top": 848, "height": 58, "left": 229}, "words": "日0.3mg倍美力开始,随后的剂量要基于患者个体临床反应和骨矿物质密度的反应进"}, {"probability": {"variance": 8e-06, "average": 0.998556, "min": 0.987743}, "location": {"width": 612, "top": 886, "height": 47, "left": 230}, "words": "行调整。剂量应该由医生定期进行评价,决定治疗是否仍然必要"}, {"probability": {"variance": 2e-06, "average": 0.998883, "min": 0.993833}, "location": {"width": 823, "top": 933, "height": 55, "left": 231}, "words": "根据患者个体情况及医疗需要,倍美力可以采用不间断的连续疗法,或者周期性用药"}, {"probability": {"variance": 2.9e-05, "average": 0.996764, "min": 0.978814}, "location": {"width": 399, "top": 974, "height": 46, "left": 232}, "words": "方案(如服药25天,随后停药5天的疗法)"}, {"probability": {"variance": 0.001054, "average": 0.992348, "min": 0.81142}, "location": {"width": 718, "top": 1021, "height": 53, "left": 194}, "words": "3.治疗因性腺功能减退、去势或原发性卵巢功能衰退所致的雌激素低下症"}, {"probability": {"variance": 0.000944, "average": 0.989398, "min": 0.854335}, "location": {"width": 815, "top": 1047, "height": 55, "left": 232}, "words": "女性性腺功能减退:每天0.3mg或0.625mg,周期性服用(如服药三周停药周)。根"}, {"probability": {"variance": 6e-06, "average": 0.998219, "min": 0.9901}, "location": {"width": 483, "top": 1086, "height": 44, "left": 232}, "words": "据症状的轻重程度和子宫内膜的反应进行剂量调整"}, {"probability": {"variance": 0.002632, "average": 0.983831, "min": 0.764275}, "location": {"width": 814, "top": 1129, "height": 55, "left": 234}, "words": "在对因女性性腺功能减退引起的青春期延迟的临床研究中,用0.15mg的低剂量就可诱"}, {"probability": {"variance": 0.005575, "average": 0.986122, "min": 0.526356}, "location": {"width": 821, "top": 1159, "height": 53, "left": 235}, "words": "导乳房发育。在6-12个月的间期,剂量可以逐渐上调,直至达到适当骨龄增加和最终"}, {"probability": {"variance": 0.001066, "average": 0.987169, "min": 0.818697}, "location": {"width": 826, "top": 1186, "height": 57, "left": 231}, "words": "骨骺闭合。临床研究提示用药剂量为0.15mg、0.30mg和0.6mg,对应的骨龄和年龄比率"}, {"probability": {"variance": 0.011177, "average": 0.949398, "min": 0.581781}, "location": {"width": 815, "top": 1218, "height": 53, "left": 232}, "words": "(△BA/△CA)分别为1.1、1.5和2.1。(倍美力无规格为0.15mg的产品)。已有的数据"}, {"probability": {"variance": 0.007324, "average": 0.977053, "min": 0.545706}, "location": {"width": 814, "top": 1246, "height": 53, "left": 234}, "words": "提示,配合序贯使用孕激素,长期服用0.625mg的倍美力,足以产生人工周期,并可"}, {"probability": {"variance": 2.2e-05, "average": 0.998119, "min": 0.982118}, "location": {"width": 290, "top": 1291, "height": 38, "left": 235}, "words": "在骨骼成熟后保持骨矿物密度"}, {"probability": {"variance": 0.001371, "average": 0.988281, "min": 0.812008}, "location": {"width": 811, "top": 1329, "height": 53, "left": 237}, "words": "去势或原发性卵巢功能衰退:每天1.25mg,周期性服用。根据症状严重程度和患者的"}, {"probability": {"variance": 0.000338, "average": 0.995567, "min": 0.89065}, "location": {"width": 744, "top": 1360, "height": 51, "left": 237}, "words": "反应,上下调整剂量。为保持疗效,可将剂量调整到有效控制病情的最低剂量"}, {"probability": {"variance": 0.009149, "average": 0.963938, "min": 0.570771}, "location": {"width": 618, "top": 1414, "height": 53, "left": 237}, "words": "治疗适当选择的女性和男性转移性乳腺癌患者(仅用于缓解症状"}, {"probability": {"variance": 0.024528, "average": 0.924369, "min": 0.488362}, "location": {"width": 423, "top": 1453, "height": 40, "left": 238}, "words": "建议每天三次,每次0mg,持续至少三个局"}, {"probability": {"variance": 0.026947, "average": 0.916094, "min": 0.417829}, "location": {"width": 481, "top": 1504, "height": 46, "left": 238}, "words": "治疗晚期雄激索依赖性列腺人仅用于缓解症状"}, {"probability": {"variance": 0.00012, "average": 0.991571, "min": 0.970322}, "location": {"width": 149, "top": 1497, "height": 77, "left": 695}, "words": "质量管理部"}], "language": 3}